Abstract

To examine the comparative robustness of computed tomography (CT)-based conventional radiomics and deep-learning convolutional neural networks (CNN) to predict overall survival (OS) in HCC patients. Retrospectively, 114 HCC patients with pretherapeutic CT of the liver were randomized into a development (n = 85) and a validation (n = 29) cohort, including patients of all tumor stages and several applied therapies. In addition to clinical parameters, image annotations of the liver parenchyma and of tumor findings on CT were available. Cox-regression based on radiomics features and CNN models were established and combined with clinical parameters to predict OS. Model performance was assessed using the concordance index (C-index). Log-rank tests were used to test model-based patient stratification into high/low-risk groups. The clinical Cox-regression model achieved the best validation performance for OS (C-index [95% confidence interval (CI)] 0.74 [0.57–0.86]) with a significant difference between the risk groups (p = 0.03). In image analysis, the CNN models (lowest C-index [CI] 0.63 [0.39–0.83]; highest C-index [CI] 0.71 [0.49–0.88]) were superior to the corresponding radiomics models (lowest C-index [CI] 0.51 [0.30–0.73]; highest C-index [CI] 0.66 [0.48–0.79]). A significant risk stratification was not possible (p > 0.05). Under clinical conditions, CNN-algorithms demonstrate superior prognostic potential to predict OS in HCC patients compared to conventional radiomics approaches and could therefore provide important information in the clinical setting, especially when clinical data is limited.

Details

Title
Comparative analysis of radiomics and deep-learning algorithms for survival prediction in hepatocellular carcinoma
Author
Schön, Felix 1 ; Kieslich, Aaron 2 ; Nebelung, Heiner 1 ; Riediger, Carina 3 ; Hoffmann, Ralf-Thorsten 1 ; Zwanenburg, Alex 4 ; Löck, Steffen 2 ; Kühn, Jens-Peter 1 

 Faculty of Medicine and University Hospital Carl Gustav Carus, TU Dresden, Institute and Polyclinic for Diagnostic and Interventional Radiology, Dresden, Germany (GRID:grid.4488.0) (ISNI:0000 0001 2111 7257) 
 Faculty of Medicine and University Hospital Carl Gustav Carus, TU Dresden, Helmholtz-Zentrum Dresden-Rossendorf, OncoRay‑National Center for Radiation Research in Oncology, Dresden, Germany (GRID:grid.4488.0) (ISNI:0000 0001 2111 7257) 
 Faculty of Medicine and University Hospital Carl Gustav Carus, TU Dresden, Department of Visceral, Thoracic and Vascular Surgery, Dresden, Germany (GRID:grid.4488.0) (ISNI:0000 0001 2111 7257) 
 Faculty of Medicine and University Hospital Carl Gustav Carus, TU Dresden, Helmholtz-Zentrum Dresden-Rossendorf, OncoRay‑National Center for Radiation Research in Oncology, Dresden, Germany (GRID:grid.4488.0) (ISNI:0000 0001 2111 7257); National Center for Tumor Diseases (NCT/UCC) Dresden, Dresden, Germany (GRID:grid.461742.2) (ISNI:0000 0000 8855 0365); German Cancer Research Center (DKFZ), Heidelberg, Germany (GRID:grid.7497.d) (ISNI:0000 0004 0492 0584) 
Pages
590
Publication year
2024
Publication date
2024
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2910735628
Copyright
© The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.